Francisella tularensis (Tularemia)

Last updated: November 01, 2022

Francisella tularensis (Tularemia)

I&D Part 1

I&D Part 1

Thymus histology
Spleen histology
Lymph node histology
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Abscesses
Anaphylaxis
Rheumatic heart disease
Poststreptococcal glomerulonephritis
Contact dermatitis
X-linked agammaglobulinemia
Thymic aplasia
DiGeorge syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus viridans
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Streptococcus agalactiae (Group B Strep)
Enterococcus
Clostridium perfringens
Clostridium botulinum (Botulism)
Clostridium difficile (Pseudomembranous colitis)
Clostridium tetani (Tetanus)
Bacillus cereus (Food poisoning)
Listeria monocytogenes
Bacillus anthracis (Anthrax)
Nocardia
Escherichia coli
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Pseudomonas aeruginosa
Enterobacter
Klebsiella pneumoniae
Shigella
Yersinia enterocolitica
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Bacteroides fragilis
Yersinia pestis (Plague)
Vibrio cholerae (Cholera)
Helicobacter pylori
Campylobacter jejuni
Neisseria meningitidis
Neisseria gonorrhoeae
Moraxella catarrhalis
Francisella tularensis (Tularemia)
Bordetella pertussis (Whooping cough)
Brucella
Haemophilus influenzae
Haemophilus ducreyi (Chancroid)
Mycoplasma pneumoniae
Chlamydia pneumoniae
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Viral structure and functions
Varicella zoster virus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Human papillomavirus
Poxvirus (Smallpox and Molluscum contagiosum)
HIV (AIDS)
Poliovirus
Coxsackievirus
Rhinovirus
Influenza virus
Respiratory syncytial virus
Human parainfluenza viruses
Dengue virus
Yellow fever virus
Zika virus
West Nile virus
Norovirus
Rotavirus
Coronaviruses
Ebola virus
Rabies virus
Rubella virus
Eastern and Western equine encephalitis virus
Candida
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications

Flashcards

Francisella tularensis (Tularemia)

0 of 7 complete

Transcript

Watch video only

Content Reviewers

Francisella tularensis is a Gram-negative coccobacillus, which means that shape-wise, it’s somewhere between a spherical coccus and a rod-like bacillus.

In humans, it causes a zoonotic infection called tularemia, also called rabbit fever.

This bacteria is also considered a category A bioterrorism agent which means it is of highest concern for bioterrorism use, because of its low infectious dose and high associated mortality.

Now, Francisella tularensis has a thin peptidoglycan layer, so it doesn’t retain the crystal violet dye during Gram staining.

Instead, like any other Gram-negative bacteria, it stains pink with safranin dye.

Alright, now Francisella tularensis is non-motile, non-spore forming, facultative intracellular which means it can survive both outside and inside the cell and aerobic which means it can survive only in the presence of oxygen.

Also, it’s oxidase and urease negative which means it doesn’t produce these enzymes.

Finally, Francisella tularensis is a fastidious bacteria which requires enriched medium for growth.

And Francisella tularensis really loves cysteine, so it only grows in about 47 to 72 hours on cysteine-enriched mediums like cysteine enriched chocolate agar, BCYE and CHAB.

Cysteine enriched chocolate agar, named so for its color, actually contains cysteine and lysed red blood cells - so no chocolate products were harmed in the making of this medium.

BCYE stands for buffered charcoal yeast extract, so it contains activated charcoal, yeast extract, and L-cysteine.

On these two mediums, Francisella tularensis forms round, grey-white colonies.

Finally, CHAB is a glucose cysteine agar that contains thiamine and blood, and on CHAB, Francisella tularensis forms greenish-white, round, smooth, mucoid colonies.

Now, Francisella tularensis has a number of virulence factors, that are like assault weaponry that help it attack and destroy the host cells, and evade the immune system.

So first, Francisella tularensis is encapsulated, meaning it’s covered by a polysaccharide layer called a capsule.

And right underneath that capsule, there’s also an outer membrane, which consists of lipopolysaccharide - or LPS for short.

The most interesting part is that normally, the LPS of Gram-negative bacteria binds to a protein found on immune cells like macrophages, called Toll-like receptor 4, or TLR4 for short, which is involved in the activation of innate immune system.

And this leads to the production of pro-inflammatory cytokines and nitric oxide that neutralize the invader.

However, the LPS of Francisella tularensis is inactive which means that TLR4 does not bind to it, so the innate immune system does not get activated - so it’s kinda like a thief breaking into a house without triggering the alarm.

So next, Francisella tularensis uses its type IV pili, which are hair-like extensions found on its capsule, to attach to macrophages.

Once attached to macrophages, the bacteria is ingested, and it gets wrapped up in a vesicle called a phagosome.

Normally, the phagosome would merge with the lysosome, to form a phagolysosome and subject the invader to oxidative burst - which is when damaging free radicals are released inside the phagolysosome.

However, Francisella tularensis produce an acid phosphatase, called AcpA, which inhibits the fusion between phagosome and lysosome, helping it avoid intracellular destruction.

And now, Francisella tularensis can replicate safely inside the macrophage.

And to replicate, it needs iron, so it also produces a siderophore, which is a term used for a group of small, high-affinity, iron chelating compounds that snatch iron from host cells.

Eventually, after Francisella tularensis has replicated enough, the macrophage bursts and releases the bacteria into the bloodstream, causing sepsis.

From the bloodstream, it can spread to other organs like the lymph nodes, causing inflammation and suppuration, or pus formation.

Alternatively, it can spread to the liver, causing hepatitis, the kidneys, causing renal failure, or the lungs, causing pneumonia.

Key Takeaways

Francisella tularensis is a gram-negative, facultative intracellular coccobacillus, known to cause a zoonotic infection known as tularemia. Tularemia can be transmitted to humans by ticks, deer flies, rabbits, and deer flies.

Depending on the transmission route, tularemia has several forms, including ulceroglandular, oculoglandular, and pneumonic. The ulceroglandular form occurs when the bacteria enter through a break in the skin. The ulcer at the site of infection becomes swollen and painful, and may discharge pus. Glands near the ulcer may also become enlarged. Next, the oculoglandular form occurs when the bacteria are spread to the eyes. Symptoms include redness, swelling, and pain in the eyes, photophobia, as well as swollen lymph nodes., Finally, the pneumonic form occurs when the bacteria are inhaled and resulting in pneumonia. Symptoms include fever, chest pain, and coughing up blood.